Microbix Biosystems' market value is the price at which a share of Microbix Biosystems trades on a public exchange. It measures the collective expectations of Microbix Biosystems investors about its performance. Microbix Biosystems is trading at 0.16 as of the 22nd of January 2026. This is a 11.11% down since the beginning of the trading day. The stock's lowest day price was 0.16. With this module, you can estimate the performance of a buy and hold strategy of Microbix Biosystems and determine expected loss or profit from investing in Microbix Biosystems over a given investment horizon. Check out Microbix Biosystems Correlation, Microbix Biosystems Volatility and Microbix Biosystems Alpha and Beta module to complement your research on Microbix Biosystems.
Please note, there is a significant difference between Microbix Biosystems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbix Biosystems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbix Biosystems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Microbix Biosystems 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Microbix Biosystems' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Microbix Biosystems.
0.00
10/24/2025
No Change 0.00
0.0
In 3 months and 1 day
01/22/2026
0.00
If you would invest 0.00 in Microbix Biosystems on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Microbix Biosystems or generate 0.0% return on investment in Microbix Biosystems over 90 days. Microbix Biosystems is related to or competes with Celyad Oncology, Starpharma Holdings, Finch Therapeutics, and Defence Therapeutics. Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological s... More
Microbix Biosystems Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Microbix Biosystems' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Microbix Biosystems upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbix Biosystems' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Microbix Biosystems' standard deviation. In reality, there are many statistical measures that can use Microbix Biosystems historical prices to predict the future Microbix Biosystems' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Microbix Biosystems. Your research has to be compared to or analyzed against Microbix Biosystems' peers to derive any actionable benefits. When done correctly, Microbix Biosystems' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Microbix Biosystems.
Microbix Biosystems January 22, 2026 Technical Indicators
Microbix Biosystems has Sharpe Ratio of -0.0248, which conveys that the firm had a -0.0248 % return per unit of risk over the last 3 months. Microbix Biosystems exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Microbix Biosystems' Risk Adjusted Performance of (0.01), mean deviation of 2.15, and Standard Deviation of 4.19 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.39, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Microbix Biosystems will likely underperform. At this point, Microbix Biosystems has a negative expected return of -0.1%. Please make sure to verify Microbix Biosystems' variance, skewness, period momentum indicator, as well as the relationship between the total risk alpha and day median price , to decide if Microbix Biosystems performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.22
Weak reverse predictability
Microbix Biosystems has weak reverse predictability. Overlapping area represents the amount of predictability between Microbix Biosystems time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Microbix Biosystems price movement. The serial correlation of -0.22 indicates that over 22.0% of current Microbix Biosystems price fluctuation can be explain by its past prices.
Other Information on Investing in Microbix OTC Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.